Sabra Healthcare REIT, Inc.
SBRA Real Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024. In the quarter to June 2026, revenue grew 24.7%, EPS fell 135.7%, free cash flow fell 666.1% and total debt rose 5.91%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three.
Follow SBRA
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Net Income |
+8 more quarters Free account |
22.52 | 27.15 | 40.81 | (25.25) |
Depreciation & Amortization |
48.51 | 51.41 | 53.13 | 56.38 | |
Non Cash Items (Other) |
20.76 | 13.14 | 3.84 | 67.87 | |
Accounts Receivable Change |
(2.26) | (2.32) | (1.53) | (10.39) | |
Change in payables and accrued liability |
10.44 | (1.94) | 2.11 | (2.80) | |
Operating Cash Flow |
99.96 | 87.43 | 98.36 | 85.82 | |
Capital expenditures |
(207.95) | (123.16) | (107.95) | (209.74) | |
Long-Term Investments Change (Net) |
0.00 | 0.00 | (0.01) | (0.65) | |
Other investing activities |
8.12 | 6.61 | 2.88 | 296.89 | |
Investing cash flow |
(199.84) | (116.55) | (105.09) | 86.50 | |
Repayment/Issuance of Debt (Net) |
119.14 | (65.53) | 137.27 | (37.53) | |
Equity Repurchase (Common, Net) |
164.14 | 39.43 | (8.25) | 55.95 | |
Dividends Paid (Total) |
(71.94) | (74.80) | (75.66) | (75.66) | |
Other financial activities |
(5.17) | 0.01 | (1.27) | (0.12) | |
Financing cash flow |
206.17 | (100.89) | 52.10 | (57.36) | |
Exchange Rate Adjustment |
(0.43) | 0.64 | (0.06) | (0.07) | |
Change in Cash |
105.87 | (129.38) | 45.31 | 114.89 | |
Beginning Cash |
0.00 | 0.00 | 78.14 | 0.00 | |
Ending Cash |
105.87 | (129.38) | 123.45 | 114.89 | |
Stock Based Compensation |
2.88 | 3.07 | 3.10 | 4.09 | |
Dividends Paid (Common) |
(71.94) | (74.80) | (75.66) | (75.66) | |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
8.17 | (4.26) | 0.58 | (13.18) | |
Investments Change (Net) |
0.00 | 0.00 | (0.01) | (0.65) | |
Issuance/Purchase of Shares |
164.14 | 39.43 | (8.25) | 55.95 |